Active — Not RecruitingNot Applicable

Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors

United States133 participantsStarted 2007-11-15

Plain-language summary

The goal of this clinical research study is to use computed tomography urography (CTU) scans and intravenous urography (IVU) scans to check the status of urothelial cancer, in order to try to learn the level of effectiveness of possibly using CTU by itself in future patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients who will undergo IVU using digital tomosynthesis and staging abdomino-pelvic CT as part of their routine care will be invited to participate in this study.
✓. Patients who have been referred for CTU will also be invited to participate in the study.
✓. Such patients will typically
✓. Have histologically proven TCC, or
✓. Have bladder tumors of Stage ≥ T3, or
✓. Had cystectomies for bladder cancer, or
✓. Upper tract TCC.
✓. \>18 years age.

Exclusion criteria

✕. Elevated serum creatinine of \>2
✕. Allergy to intravenous CT contrast media
✕. Ureteral stint present or removed within six weeks
✕. Women of child bearing potential

What they're measuring

CTU to IVU Technical Performance Comparison: Opacification + Ability to Visualize Urothelial Segments

Timeframe: 2 Years

Trial details

NCT IDNCT00567684

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2034-11-30

View on ClinicalTrials.gov More Bladder Cancer trials